Related Posts

• 
  CSO Dr Daniel Tillett talks to Small Caps about Race Oncology's Plans for 2022 and beyond

  https://youtu.be/feGtU2ARdo8

• 
  Dr Daniel Tillett joins Race Board

  17 September 2019 – Race Oncology Limited (ASX: RAC) is pleased to announce that prominent biotechnology…

• 
  Race appoints Dr Daniel Tillett Chief Scientific Officer

  Race Oncology is pleased to announce that Dr Daniel Tillett has been appointed Chief Scientific…